Background

STAT Research is a medical and scientifically-driven Clinical Research Organization (CRO) with headquarters in Buenos Aires, Argentina, focused on Neurology, Psychiatry and Vascular Diseases (Hypertension, Lipids, Diabetes, CHF).

Conrado J. Estol, M.D., Ph.D., FAAN, the Chief Scientific Officer and founder of STAT Research, has 25 years’ experience in Clinical Trials, including the first studies that tested effective Stroke therapies. Fully trained in internal medicine, neurology and cerebrovascular disease in the USA and certified by the American Board of Psychiatry and Neurology, Dr. Estol is an academic researcher with business expertise and strategic vision.

With strong academic and research backgrounds, our highly-qualified team understands sponsor’s needs and is able to actively react in response to these. Experience, reputation, network, vision and passion are part of STAT Research’s strategies in creating a sustainable growing business in a rapidly expanding market.

STAT Research works closely with study sponsors to understand all organizational aspects of each Clinical Trial conducted.

In depth knowledge of local regulations, a personalized care, a large number of regulatory and organizational tasks performed by MD’s and specialization in the recruitment of patients at lower costs are among the competitive advantages of STAT Research in a business-challenged environment.

In relation and constant interaction with prestigious national and international
academic and research centers, STAT Research works with a network of local sites and investigators in order to recruit, enroll, and timely schedule patients to participate in clinical trials.